MSLN and neoplasm: In the present study, we improved the model by incorporating several new features and applied the improved model on two systems, the immunotoxin LMB-2 targeting CD25 of the ATAC-4 cell tumor as well as the original SS1P targeting mesothelin of the A431/H9 cell tumor.